Companies/JP/2395

株式会社新日本科学 · SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

Ownership & governance

Executives 5Directors 10Avg age 57Avg tenure 8.2y
Ryoichi Nagata
Chief Executive Officer
Age 67Since 2014-03-31

Executives5

Ryoichi Nagata
Chief Executive Officer
Age 67Since 2014-03-31
Hideyuki Hirama
President
Age 49Since 2026-06-25
Takashi Iriyama
Director of Finance/CFO
——
Yukihiro Kiya
Chief Tech/Sci/R&D Officer
——
Ichiro Nagata
Corporate Officer/Principal
Age 40Since 2023-05-31

Board of directors10

Ryoichi Nagata
Chairman
Age 67Since 2014-05-31
Ken Takanashi
Director/Board Member
Age 62Since 2004-05-31
Hideshi Tsusaki
Director/Board Member
Age 59Since 2010-05-31
Shinichi Fukumoto
Director/Board Member
Age 68Since 2015-05-31
Takashi Yamashita
Director/Board Member
Age 70Since 2015-05-31
Ichiro Nagata
Director/Board Member
Age 40Since 2020-06-25
Tsuyoshi Hanada
Director/Board Member
—Since 2020-06-25
Keiko Toya
Director/Board Member
Age 62Since 2021-05-31

Shareholders5

NameStakeShares
Nagata Family
40.33 %
16,788,600
Sumitomo Mitsui DS Asset Management Co., Ltd.
5.53 %
2,302,400
Asset Management One Co., Ltd.
5.043 %
2,099,700
Takahisa Nagata
4.564 %
1,900,000
Medipolis Medical Research Institute
3.541 %
1,474,000

Catalog · 2026-07-09

Registry officers17

NameRoleSinceShares
入山 隆専務取締役CFO2019-11-01-
永田 良一代表取締役会長兼社長CEO兼CHO1981-09-01-
山下 隆取締役2015-06-01-
平間 英之代表取締役社長2009-12-01-
廣瀬 由美取締役2025-06-01-
戸谷 圭子取締役1999-07-01-
松枝 千鶴（現姓 堀下）取締役2024-06-01-
梅原 友樹取締役2017-11-01-

Registry · as of 2026-03-31

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 1,693.5Range 1,387–2,000Analysts 2
1,387Mean 1,693.52,000
  • Buy 1
  • Hold 1

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers